Liquidity & Technical
Liquidity & Technical — AUTO1 Group SE
Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, multiples and technical indicators (RSI, MACD, volatility, returns) are unitless and unchanged.
Bottom line: the binding constraint here is not the chart, it is the order book. AUTO1 trades roughly $12M a day against a $6.1B market cap — about 0.19% of the float turns over daily — so a 5% position is only implementable for funds up to ~$250M of AUM at a disciplined 20%-of-ADV participation. Above that, you become the market. On the tape itself the read is neutral with a bullish lean: price has clawed back above its 200-day after a violent February-2026 drawdown, momentum has turned up (RSI 60, MACD positive), but the Feb-2026 death cross is still unresolved and the recovery has come on declining volume. The single feature that matters most: a V-shaped +62% three-month bounce off the $17 capitulation low, reclaiming the long-term trend line but not yet confirming it.
Technical Score (−3 to +3)
Price vs 200-day
RSI(14)
3-Month Return
Realized Vol (30d)
52-Week Range Position
Source: derived from staged price, momentum and volatility series (XETRA daily, Feb-2021 to Jun-2026).
Implementation verdict — capacity is the gate. AUTO1 is institutionally tradable only in size-aware fashion: deep enough to build a position over weeks, far too thin to act with conviction in days. A 2% portfolio weight is supportable for funds up to roughly $625M of AUM; a 5% weight only up to ~$250M. Larger funds should treat this as a specialist / patient-block name. Technicals are constructive but secondary to that constraint.
Liquidity — the binding constraint
20-Day ADV ($M/day)
5-Day Capacity @20% ADV ($M)
Fund AUM for 5% Position ($M)
Days to Exit 1% of Mkt Cap
Annual Turnover (%)
Median Daily Range (%)
Source: liquidity.json — ADV over the latest 20 sessions; capacity and AUM support derived from five-day trading at 20% of ADV.
Twenty-day ADV is $11.9M (445k shares), and it has been falling — the 60-day average is $13.1M (580k shares), so recent participation has thinned even as price recovered. At a disciplined 20%-of-ADV cap, a fund can absorb about $12.5M over five trading days — roughly 0.20% of market cap. Reverse that into portfolio weights and the picture is stark: the name supports a 5% position only for AUM up to ~$250M, a 2% position up to ~$625M, and a 10% position up to just ~$125M. Execution friction itself is moderate — the median daily range is 1.76%, under the 2% impact-cost flag, with zero zero-volume days and full volume coverage over 60 sessions — so the problem is not gaps or dead days, it is sheer absolute throughput.
Source: liquidity.json liquidation runway — full exit assumed at 10% / 20% of 20-day ADV.
The runway makes the constraint concrete: even a modest 1%-of-market-cap stake ($61M) takes 25 trading days to unwind at 20% ADV — five weeks of patient selling, longer if the tape goes against you. A 2% stake is a two-and-a-half-month exit. That is the real risk in this name: not the chart, but the door. The label on the data is "illiquid / specialist only," and while the stock trades every day with healthy 56% annual turnover, the absolute $12M ADV caps any large fund well before the technical setup matters. Treat sizing as the first decision, the tape as the second.
Trend & regime — above the 200-day, but the cross hasn't healed
Source: prices_daily.json and moving_averages.json, sampled to ~45 points; full daily series spans 2021-02-04 to 2026-06-19.
AUTO1 IPO'd in February 2021 at $67 — which remains the all-time high — then bled to an all-time low of $3.65 in early 2024 as the unprofitable growth story de-rated. The turn since has been spectacular: from the lows the stock is up roughly 7x, +202% over three years, peaking at a 52-week high of $37 in November 2025. Then came a sharp regime test — a slide to ~$17 through February–March 2026 that printed the death cross on 17 Feb 2026 (50-day crossing below the 200-day) — followed by the current +62% three-month V-recovery back to $28.06.
Today price sits +3.2% above its 200-day ($27.18) and well above its rising 50-day ($23.77): I classify the regime as above the 200-day, recovering uptrend. The honest caveat is structural — the 50-day is still below the 200-day, so the Feb-2026 death cross has not been reversed; a fresh golden cross would require the 50-day to climb back through the 200-day, which is several weeks away at the current slope. This is a reclaimed trend line, not yet a confirmed one.
Source: momentum.json returns block (price-only; returns are unitless and identical across currencies).
The horizon split tells the whole tension: explosive near term (+20.6% 1M, +62% 3M) but negative over six months (−10.2%), YTD (−13.2%) and flat-ish over one year (+5.2%). The stock is bouncing hard inside a still-incomplete repair of the Q1-2026 drawdown.
Momentum — turned up, not yet stretched
Source: momentum.json RSI(14), sampled (indicator is unitless, unchanged across currencies).
RSI bottomed at a deeply oversold 24.5 on 19 Feb 2026 — the capitulation that marked the low — and has rebuilt to 60.4: firmly in bullish territory but not overbought (no readings above 70 on the current leg), which leaves room before the move is stretched. This is the constructive part of the tape.
Source: momentum.json MACD (12/26/9), unitless and unchanged across currencies.
MACD confirms the momentum turn: it collapsed to −2.5 at the February low, then crossed back above its signal line and is now positive and expanding (line 1.23 vs signal 1.06, histogram +0.17). Both oscillators agree — momentum has flipped from washout to recovery. The asterisk is that MACD whipsawed repeatedly through 2025 (multiple signal-line crosses), a hallmark of a high-volatility, choppy name where momentum signals decay fast.
Volume, volatility & sponsorship
Realized Vol 30d (%)
10-Yr 80th-pct Vol (%)
ATR(14) ($)
Source: volatility.json — 30-day realized vol, 10-year percentile bands, ATR(14).
Realized volatility is 63%, sitting between the 50th (53.9%) and 80th (70.2%) percentiles of its ten-year range — an elevated-risk regime. ATR(14) of $0.89 on a $28.06 stock means roughly 3% of intraday range is normal noise. For a fund, that is the risk-premium read: the market is demanding a wide band around this name, so position sizing and stops must be set wider than the fundamentals alone would suggest, and any technical "level" carries a ±3% halo.
Source: unusual_volume.json top-10 volume-spike days (no catalyst metadata staged).
The volume signature carries a warning. The heaviest recent volume came on down days, not up days — the 25 Feb 2026 capitulation (−18.2% on 6.8× average volume) and the 17 Feb breakdown were distribution events, and the largest spike of all (15.7× in June 2021) was selling into the post-IPO decline. The lone high-conviction up spike is November 2024 (+13.3% on 9.1×), which marked the start of the 2024-25 recovery. Critically, the current +62% bounce has come on falling volume (20-day ADV $11.9M vs 60-day $13.1M): the rally lacks an accumulation footprint, so it is being driven more by absence of sellers than by aggressive buyers. That is the kind of advance that can reverse quickly if supply returns.
Relative strength — not assessable against a usable benchmark
No sector ETF and no peer basket were staged for AUTO1, and the only broad-market reference is SPY — a USD S&P 500 proxy that is not a clean comparator for a German small/mid-cap. I will not manufacture a relative-strength signal from a mismatched benchmark. In absolute terms the magnitude speaks for itself: +202% over three years dwarfs any developed-market index over the same window, but the last twelve months (+5.2%) and year-to-date (−13.2%) show the outperformance has stalled. Relative strength is neutral / not scored for lack of a defensible benchmark.
Price vs fundamentals — the tape confirms the turn
Agreement, not divergence. The single biggest technical event — the recovery from the $3.65 low — lines up exactly with the fundamental inflection: AUTO1 posted its first net profit in FY2024 ($22M) and accelerated to $92M net income on $9.6B revenue (+30%) in FY2025. The +202% three-year rally is fundamentally underwritten, not a speculative melt-up. The tape is ratifying the profitability story, which is what makes the setup more than a dead-cat bounce.
The reverse-side caveat is valuation-aware: at $28.06 against FY2025 EPS of $0.42, the stock trades on a high multiple, which is consistent with the high realized volatility — the market is pricing continued earnings acceleration, and any miss would re-open the Q1-2026 air pocket. So tape and fundamentals agree on direction; the risk both share is that expectations are now elevated.
Technical scorecard
Source: derived from staged technical series; scoring framework fixed for cross-company comparability.
Stance — neutral, with a bullish lean, gated by liquidity
On a 3-to-6-month horizon I am neutral on AUTO1's tape, leaning constructive. The momentum picture has genuinely turned (RSI 60, MACD bullish crossover) and price has reclaimed its 200-day on the back of a real earnings inflection — but conviction is capped by an unhealed death cross, a recovery built on thinning volume, and a 63% volatility regime that makes every level fuzzy. The two levels that resolve it: a sustained close above $31.00 would pull the 50-day toward a fresh golden cross, clear the Q1-2026 breakdown zone, and confirm the bull case toward the $37 prior high; a close below $23.50 would lose both the 50-day and the recovery structure, re-exposing the $17 February lows and confirming the bear case.
The implementation sentence overrides the chart: liquidity is the binding constraint. For funds above ~$250–625M of AUM the action is build slowly over weeks or stay on the watchlist — not because the setup is wrong, but because $12M of daily liquidity will not let you express a thesis at size, or exit one, without moving the market. For smaller specialist funds the name is investable today, sized to the order book, with the levels above as the trigger map.